insights_auto
Why is BOT up ८.३३%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$ ०.०१३
arrow_upward
+८.३३%(+०.००१०) 1D
अक्टोबर २१, १६:१०:१९ GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
४.३१ करोड
Avg. vol.
८०.५१ लाख
Volume
७२.९२ लाख
52-wk high
A$ ०.१६
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
४.३१ करोड
Avg. vol.
८०.५१ लाख
Volume
७२.९२ लाख
52-wk high
A$ ०.१६
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
News stories
From web sources and news partners
Eagle-Tribune
·
३३ मिनेट पहिले
Options Expands Data Coverage with Nasdaq Options Feeds
Lookout Santa Cruz
·
४५ मिनेट पहिले
This week in Santa Cruz County business: Cruz Foam ceases operations; West Coast Community Bank celebrates Nasdaq listing
Stocktwits
·
२ घण्टा पहिले
AERO Climbs As Aerodrome, Velodrome Unite In Bid To 'Take On' NYSE, Nasdaq
Investing.com
·
५४ मिनेट पहिले
Helio Corporation files to uplist to Nasdaq with 2M share offering
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd